Excited to be featured in Times Square, NYC. Thanks, Nasdaq! #ICYMI, last week Collegium completed the acquisition of Ironshore, establishing our presence in neurology as we advance our mission to improve the lives of people living with serious medical conditions. Read more: http://bit.ly/3AU2JX6
Collegium Pharmaceutical, Inc.
Pharmaceutical Manufacturing
Stoughton, Massachusetts 15,365 followers
Healthier people. Stronger communities.
About us
Collegium Pharmaceutical is building a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a portfolio of differentiated medications to treat serious medical conditions.
- Website
-
http://www.collegiumpharma.com
External link for Collegium Pharmaceutical, Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Stoughton, Massachusetts
- Type
- Public Company
- Specialties
- Serious Medical Conditions, Responsible Pain Management, Attention Deficit Hyperactivity Disorder (ADHD), and Specialty Pharmaceutical
Locations
-
Primary
100 Technology Center Dr
Stoughton, Massachusetts 02072, US
-
Employees at Collegium Pharmaceutical, Inc.
Updates
-
Today, we announced the completion of our acquisition of Ironshore and updated our 2024 financial guidance. This acquisition further advances our mission of building a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Read more: https://bit.ly/3AU2JX6
-
We’re onsite at #PAINWeek Conference 2024 this week! We are honored to present eight posters that outline the impact of our diversified product portfolio and provide important insights for healthcare leaders treating patients with pain. Visit us at Booth 304 or click here to learn more: https://bit.ly/3X2Fd1o
-
Today Collegium announced that eight poster presentations highlighting data from our diversified pain portfolio will be presented at the #PAINWeek Conference next week. We look forward to joining the community and demonstrating our dedication to Leading with Science. Learn more: https://bit.ly/3X2Fd1o
-
Collegium is proud of our work to improve the lives of people living with serious medical conditions and support ‘Healthier people. Stronger communities.” Our team remains as passionate as ever about our mission and making an impact. Learn more: https://bit.ly/3XHERMz
-
Tonight is your last chance of the 2024 Boston Red Sox season to visit Collegium’s booth with Science from Scientists. Stop by for family-friendly #STEM experiments! We’ve had an amazing summer, but our commitment to increasing #STEMeducation is year-round. See more: https://bit.ly/3we8FEz
-
This afternoon, Collegium reported Q2 2024 financial results. Read the press release: https://bit.ly/3yncWKK
-
Collegium is excited to announce the proposed acquisition of Ironshore. We are proud to be taking this important next step for our organization as we strive to build a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Read more: https://bit.ly/46FQ2Ln
-
Collegium is honored to be chosen as the recipient of MassBioEd Foundation’s 2024 Champion Organization for Biotechnology Education award. We look forward to celebrating in October alongside the other Champions committed to advancing #STEMEducation in our communities.
You're invited to join MassBioEd Foundation's 9th Annual Champions for Biotechnology Education Awards Gala on October 17th at the Museum of Science. We will honor the "Champions" who have gone above and beyond to advance life sciences education and workforce development across Massachusetts. Secure your ticket today! https://lnkd.in/eXBXPZuz #Champs4BioEd24 #LifeSciences #Education #WFD #MASSOpportunities
-
We’re having a great summer hosting #STEMeducation activities alongside Science from Scientists at some Boston Red Sox games! Get the details on these #STEM experiments and upcoming games – we hope to see you there! https://bit.ly/3qcT9ZT